Literature DB >> 11282012

No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative Ethiopian commercial sex workers and low-risk control subjects.

T Messele1, T F Rinke de Wit, M Brouwer, M Aklilu, T Birru, A L Fontanet, H Schuitemaker, D Hamann.   

Abstract

Host factors such as increased beta-chemokine production, HIV-1 coreceptor expression level, and HIV-1 coreceptor polymorphism have been thought to influence susceptibility to HIV-1 infection. To determine the protective role of these factors in Ethiopians who remained HIV-1 uninfected, despite multiple high-risk sexual exposures, we studied 21 Ethiopian women who had been employed as commercial sex workers (CSWs) for five or more years. The HIV-1-resistant CSWs were compared with low-risk age-matched female controls who had a comparable CD4+ cell percentage and mean fluorescence intensity (MFI). Genetic polymorphism in the CCR5, CCR2b, or SDF-1 genes appeared not to be associated with resistance in the Ethiopian CSWs. Expression levels of CCR5 and CXCR4 on naive, memory, and total CD4+ T cells tended to be higher in the resistant CSWs, while the production of beta-chemokines RANTES, MIP-1alpha, and MIP-1beta by phytohemagglutinin (PHA)-stimulated peripheral blood mononuclear cells (PBMCs) was lower compared with low-risk HIV-1 negative controls. In vitro susceptibility of PHA-stimulated PBMCs to primary, CCR5-restricted, Ethiopian HIV-1 isolates was comparable between resistant CSWs and low-risk controls. In vitro susceptibility was positively correlated to CD4+ cell mean fluorescence intensity and negatively correlated to CCR5 expression levels, suggesting that infection of PBMCs was primarily dependent on expression levels of CD4 and that CCR5 expression, above a certain threshold, did not further increase susceptibility. Our results show that coreceptor polymorphism, coreceptor expression levels, beta-chemokine production, and cellular resistance to in vitro HIV-1 infection are not associated with protection in high-risk HIV-1-negative Ethiopian CSWs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282012     DOI: 10.1089/088922201750102526

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

Review 1.  RNA interference: the molecular immune system.

Authors:  Omar Bagasra; Kiley R Prilliman
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

2.  Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs.

Authors:  Eveli Kallas; Kristi Huik; Silver Türk; Merit Pauskar; Ene-Ly Jõgeda; Marina Šunina; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Radko Avi; Irja Lutsar
Journal:  Med Microbiol Immunol       Date:  2015-12-22       Impact factor: 3.402

3.  Factors associated with CD4 lymphocyte counts in HIV-negative Senegalese individuals.

Authors:  C Mair; S E Hawes; H D Agne; P S Sow; I N'doye; L E Manhart; P L Fu; G S Gottlieb; N B Kiviat
Journal:  Clin Exp Immunol       Date:  2008-01-10       Impact factor: 4.330

4.  Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals.

Authors:  Emily C Speelmon; Devon Livingston-Rosanoff; Anthony L Desbien; Jean Lee; W David Wick; Florian Hladik; M Juliana McElrath
Journal:  AIDS Res Hum Retroviruses       Date:  2008-11       Impact factor: 2.205

5.  Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans.

Authors:  Evélyne Bégaud; Loïc Chartier; Valéry Marechal; Julienne Ipero; Josianne Léal; Pierre Versmisse; Guillaume Breton; Arnaud Fontanet; Corinne Capoulade-Metay; Hervé Fleury; Françoise Barré-Sinoussi; Daniel Scott-Algara; Gianfranco Pancino
Journal:  Retrovirology       Date:  2006-06-22       Impact factor: 4.602

6.  Cluster of differentiation 4+ cell count mean value, reference range and its influencing factors in Human Immunodeficiency Virus-seronegative pregnant women in Lagos.

Authors:  A A Akinbami; A O Dosunmu; A Adediran; A A Adewunmi; K A Rabiu; V Osunkalu; S Ajibola; E I Uche; A Adelekan
Journal:  Niger Med J       Date:  2014-03

7.  Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa.

Authors:  Stefan Petkov; Carolina Herrera; Laura Else; Susan Mugaba; Patricia Namubiru; Geoffrey Odoch; Daniel Opoka; Azure-Dee A P Pillay; Thabiso B Seiphetlo; Jennifer Serwanga; Andrew S Ssemata; Pontiano Kaleebu; Emily L Webb; Saye Khoo; Limakatso Lebina; Clive M Gray; Neil Martinson; Julie Fox; Francesca Chiodi
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

8.  Population-based CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment coverage.

Authors:  Abraham Malaza; Joël Mossong; Till Bärnighausen; Johannes Viljoen; Marie-Louise Newell
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.